CLINICAL PHARMACOLOGY SHARED RESOURCE
CLINICAL PHARMACOLOGY SHARED RESOURCE
批准号:
8255518
负责人:
LIONEL David LEWIS
金额:
$14.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AliquotAnimalsAntineoplastic AgentsApplications GrantsBackBar CodesBiologicalBiological AssayBiological ProcessBudgetsCYP2C9 geneCYP2D6 geneCalciumCancer CenterCancer Center Support GrantCellsClinicalClinical ChemopreventionClinical OncologyClinical PharmacologyClinical ProtocolsClinical ResearchClinical TrialsComputersConcentration measurementConsultationsDataData AnalysesDatabasesDetectionDevelopmentDocumentationDrug KineticsEnrollmentEpidemiologic StudiesEpidemiologyEtoposideEvaluationEvaluation StudiesFluorescenceFolateFundingFutureGenetic PolymorphismHemoglobinHigh Pressure Liquid ChromatographyIn VitroIndividualInvestigational DrugsKynurenineLaboratory ResearchLeadershipLearningLiquid substanceMailsMalignant NeoplasmsMeasurementMeasuresMethodologyModelingMolecular BiologyMonitorNorris Cotton Cancer CenterNursing ResearchOncology GroupPatient CarePatientsPerformancePeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmaceutical ServicesPharmacistsPharmacodynamicsPharmacogeneticsPharmacogenomicsPharmacology Shared ResourcePharmacotherapyPharmacy facilityPhasePilot ProjectsPlasmaPrintingProcessProtocols documentationReaderResearchResearch DesignResearch PersonnelResource SharingResourcesSalivaSamplingScanningServicesSourceSpecimenSystemTechnologyTestingTherapeutic StudiesTissue SampleTissuesTryptophanTumor TissueUGT1A1 geneUnited States National Institutes of HealthUrineWorkZebraanticancer researchbiobankcostdata modelingdesigndocetaxelin vivomembernoveloncologypre-clinicalpreclinical studyrepositoryresearch studytumorvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The primary function of the Clinical Pharmacology Shared Resource (CPSR) is to support NCCC
investigators in the design, performance, data analysis, and interpretation of clinical pharmacology objectives
in preclinical (ex-vivo and in vivo), clinical, chemoprevention, and epidemiological studies, at as low a cost as
possible. The CPSR has modified its staffing since the last submission such that it now consists of one
clinical pharmacologist, one research assistant and a part of a second research assistant, a research nursing
resource, and a part of a research pharmacist. The major CPSR services include: 1) Central processing for
biological tissue samples (e.g. cells/tumor tissue/plasma/saliva/urine) and cell samples obtained as part of
approved clinical and epidemiological protocols: these services include, but are not limited to, sampleprocessing
(including processing peripheral blood mononuclear cells), logging and storage, aliquoting, and
mail-outs; 2) (a) Development of novel drug assays (when such assays are not routinely available) using
either HPLC (UV/Fluorescence detection) or LC-MS/MS methodology, (b) Performance of drugconcentration
measurements in biological fluids and tissues for preclinical and clinical oncology studies; 3)
(a) Consultation concerning study design and pharmacokinetic and pharmacodynamic hypothesis-testing in
preclinical and clinical studies, (b) Pharmacokinetic and pharmacodynamic data analysis and modeling from
pre-clinical and clinical studies; 4) Phase-l and proof-of-principle study research nursing support services; 5)
Pharmacogenomic (PGx) assays and expertise applied to cancer drug research; and 6) Research Pharmacy
Service for oncology drug research with commercially available and investigational new drugs.
The CPSR currently provides 13 NCCC investigators with services valued at $118,881 in chargebacks for
FY 2007. NCCC members represent 76% of the total number of investigators using this facility at Dartmouth,
and their usage constitutes 87% of total CPSR usage. The total chargebacks for this core were $130,161
during FY2007, and the total operating budget was $397,951, requiring $267,789 in non-chargeback
subvention, which is derived from a combination of the NCCC CCSG and chargebacks to other sponsored
projects. This shared resource is requesting a budget of $109,722 from the NCCC CCSG for the first year of
this competitive renewal (2008-09), representing a level comparable to the current year's support, which will
provide 39% of its non-chargeback subvention needs, while the majority of costs are recovered through
chargebacks and other institutional support. This core grant budget and the other subvention sources
primarily underwrite a portion of the chargeback costs to individual NCCC investigators and provide
administrative support for oversight of this shared resource.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
-
批准号:10761171
-
项目类别:
-
资助金额:$99.92万
-
财政年份:2023
-
负责人:LIONEL David LEWIS
-
依托单位:
Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors
-
批准号:10261525
-
项目类别:
-
资助金额:$101.56万
-
财政年份:2020
-
负责人:LIONEL David LEWIS
-
依托单位:
Toxicology, Pathology and Biodistribution Core (TPB Core)
-
批准号:7982610
-
项目类别:
-
资助金额:$9.59万
-
财政年份:2010
-
负责人:LIONEL David LEWIS
-
依托单位:
CLINICAL PHARMACOLOGY SHARED RESOURCE
-
批准号:7944619
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2009
-
负责人:LIONEL David LEWIS
-
依托单位:
PROTOCOL REVIEW AND MONITORING SYSTEM
-
批准号:7944683
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2009
-
负责人:LIONEL David LEWIS
-
依托单位:
Clinical Molecular
-
批准号:6989452
-
项目类别:
-
资助金额:$10.23万
-
财政年份:2004
-
负责人:LIONEL David LEWIS
-
依托单位:
Clinical Pharmacology (CP)
-
批准号:10554245
-
项目类别:
-
资助金额:$10.99万
-
财政年份:1997
-
负责人:LIONEL David LEWIS
-
依托单位:
Clinical Pharmacology (CP)
-
批准号:8804008
-
项目类别:
-
资助金额:$11.82万
-
财政年份:1997
-
负责人:LIONEL David LEWIS
-
依托单位:
Clinical Pharmacology (CP)
-
批准号:10311226
-
项目类别:
-
资助金额:$10.99万
-
财政年份:1997
-
负责人:LIONEL David LEWIS
-
依托单位:
Protocol Review and Monitoring System (PRMS)
-
批准号:10554303
-
项目类别:
-
资助金额:$7.1万
-
财政年份:1997
-
负责人:LIONEL David LEWIS
-
依托单位:
Protocol Review and Monitoring System (PRMS)
-
批准号:10311241
-
项目类别:
-
资助金额:$7.1万
-
财政年份:1997
-
负责人:LIONEL David LEWIS
-
依托单位:
Clinical Molecular
-
批准号:7332202
-
项目类别:
-
资助金额:$23.96万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
Clinical Pharmacology (CP)
-
批准号:9561223
-
项目类别:
-
资助金额:$0.18万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
PROTOCOL REVIEW AND MONITORING SYSTEM
-
批准号:8255530
-
项目类别:
-
资助金额:$4.33万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
CLINICAL PHARMACOLOGY SHARED RESOURCE
-
批准号:8015000
-
项目类别:
-
资助金额:$16.12万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
Toxicology, Pathology and Biodistribution Core (TPB Core)
-
批准号:8710053
-
项目类别:
-
资助金额:$15.85万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
CLINICAL PHARMACOLOGY SHARED RESOURCE
-
批准号:8787215
-
项目类别:
-
资助金额:$12.44万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
Protocol Review and Monitoring (PRMS)
-
批准号:9204745
-
项目类别:
-
资助金额:$6.39万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
Protocol Review and Monitoring (PRMS)
-
批准号:9758112
-
项目类别:
-
资助金额:$0.17万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
CLINICAL PHARMACOLOGY SHARED RESOURCE
-
批准号:8376245
-
项目类别:
-
资助金额:$14.23万
-
财政年份:--
-
负责人:LIONEL David LEWIS
-
依托单位:
海外基金